Alternatives to Vividion Therapeutics

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Nimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

AI research lab developing frontier models for protein design and biological discovery.

Developing engineered biologics to harness the immune system for disease treatment.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

Leveraging the adaptive immune system to diagnose and treat disease.

AI-guided drug discovery platform for tissue-targeted medicines.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Biopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.